Trial Profile
The impact of omalizumab on healthcare utilization and quality of life in patients with severe persistent asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 18 Mar 2015 New trial record